$TECH News

Are Wall Street Analysts Bullish on Bio-Techne Stock?

Bio-Techne Corp (NASDAQ:TECH) Passes the Caviar Cruise Screen with Flying Colors

The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call

RBC Capital Reinstates Outperform on Bio-Techne, Announces $62 Price Target

Baron Asset Fund Sold Bio-Techne Corporation (TECH) Due to Concerns Over Potential Impact of AI

There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings

Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Investment Firm Sells $12.2 Million Worth of Materials Stock, According to Latest SEC Filing

Citigroup Maintains Buy on Bio-Techne, Lowers Price Target to $70

Wells Fargo Maintains Overweight on Bio-Techne, Lowers Price Target to $62

Evercore ISI Group Maintains In-Line on Bio-Techne, Lowers Price Target to $50

Bio-Techne Q3 Earnings Call Highlights

Why Bio-Techne (TECH) Is Up 5.9% After Profits Rose Despite Slightly Lower Sales – And What's Next

Bio-Techne Corporation Q3 2026 Earnings Call Summary

Bio-Techne (TECH) Q3 2026 Earnings Transcript

Bio-Techne (TECH) Q1 2025 Earnings Transcript

TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin Up

Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript

Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

Techne (TECH) Misses Q3 Earnings and Revenue Estimates